We are live on ! Find out more
KCM

Kalehua Capital Management Portfolio holdings

AUM $174M
This Fund
S&P 500
This Quarter Est. Return
+45.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$174M
AUM Growth
+$32.6M
Cap. Flow
+$3.44M
Cap. Flow %
1.98%
Top 10 Hldgs %
70.75%
Holding
33
New
8
Increased
3
Reduced
2
Closed
7

Top Buys

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$5.95M
2
IFRX icon
InflaRx
IFRX
+$5.45M
3
CYCN icon
Cyclerion Therapeutics
CYCN
+$5.36M
4
KRRO icon
Korro Bio
KRRO
+$3.67M
5
ANL
Adlai Nortye Group ADS
ANL
+$2.76M

Top Sells

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$8.97M
2
ORKA
Oruka Therapeutics
ORKA
+$5.81M
3
QURE icon
uniQure
QURE
+$5.54M
4
PEPG icon
PepGen
PEPG
+$1.77M
5
TNYA icon
Tenaya Therapeutics
TNYA
+$1.38M

Sector Composition

Rank Sector Weight
1 Healthcare 84.78%
2 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCRX icon
26
TScan Therapeutics
TCRX
$54.2M
$446K 0.26%
+454,876
New +$485K
DMAC icon
27
DiaMedica Therapeutics
DMAC
$352M
– –
-62,488
Closed -$423K
LOOP icon
28
Loop Industries
LOOP
$29.9M
– –
-347,539
Closed -$361K
PEPG icon
29
PepGen
PEPG
$221M
– –
-1,000,000
Closed -$1.77M
RLAY icon
30
Relay Therapeutics
RLAY
$4.33B
– –
-901,457
Closed -$8.97M
TNYA icon
31
Tenaya Therapeutics
TNYA
$151M
– –
-2,000,000
Closed -$1.38M
ORKA
32
Oruka Therapeutics
ORKA
$6.78B
– –
-118,524
Closed -$5.81M
KLRS
33
Kalaris Therapeutics
KLRS
$97.6M
– –
-135,585
Closed -$782K
1
2

Similar funds

PWSG
Pacific Wealth Strategies Group Santa Barbara, California $174M AUM 21.47% 1-Year Est. Return
6SA
6th Street Advisors Daphne, Alabama $174M AUM
NWA
Northwest Wealth Advisors Bellingham, Washington $174M AUM
PIA
Prakash Investment Advisors Andover, Massachusetts $174M AUM 85.35% 1-Year Est. Return
CPCP
Cedar Point Capital Partners Cedar Rapids, Iowa $174M AUM 19.71% 1-Year Est. Return
PMSA
Patrick M. Sweeney & Associates Libertyville, Illinois $174M AUM 29.38% 1-Year Est. Return
MCM
MontVue Capital Management Lynchburg, Virginia $174M AUM 24.95% 1-Year Est. Return
AIA
Accelerate Investment Advisors Aliso Viejo, California $174M AUM 23.04% 1-Year Est. Return

Kalehua Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Kalehua Capital Management held 33 positions worth $174M, up 23% from $141M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Kalehua Capital Management's Q2 2026 filing shows 8 new, 3 increased, 2 reduced and 7 closed positions. Its largest new stake was Karyopharm Therapeutics: 685,644 shares worth $6.7M. The largest sale was Relay Therapeutics, an estimated $8.97M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 82% a quarter earlier, followed by Materials.

  • Kalehua Capital Management's largest Q2 2026 buy was Karyopharm Therapeutics: 685,644 shares worth $6.7M.
  • Kalehua Capital Management added most to Korro Bio in Q2 2026, an estimated $3.67M increase.
  • Kalehua Capital Management's biggest Q2 2026 reduction was uniQure, cutting an estimated $5.54M.
  • Kalehua Capital Management fully exited Relay Therapeutics in Q2 2026, selling an estimated $8.97M.
  • Kalehua Capital Management's ten largest holdings make up 71% of its $174M portfolio in Q2 2026.
  • Kalehua Capital Management opened 8 new positions and closed 7 in Q2 2026.
  • Kalehua Capital Management's portfolio value rose 23% quarter-over-quarter to $174M.

Based on Kalehua Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.